PACTR202306614083752

Effects of melatonin administration and physical exercise during Ramadan diurnal intermittent Fasting on overweight/obesity management

Concomittant effects of melatonin supplementation combined with concurrent training during Ramadan diurnal intermittent fasting on sleep quality, quality of life, postural balance and biological responses in Women With Overweight/Obesity
Research Laboratory molecular bases of human pathology LR19ES13 Faculty of medicine of Sfax·Phase 3·Pan Africa Clinical Trials RegistryCompleted
Study focus
Sponsor & location
Primary sponsor
Research Laboratory molecular bases of human pathology LR19ES13 Faculty of medicine of Sfax
Location
Tunisia
Timeline & enrollment
Phase
Phase 3
Start date
Apr 23, 2020
End date
Apr 25, 2020
Summary

Several strategies including physical activity and intermittent fasting (IF) were prescribed in the management of obesity and its associated complications. Ramadan diurnal intermittent fasting is a distinctive model of intermittent fasting; however, it is associated with decreased melatonin levels, disturbances in nocturnal sleep time, physical activity and energy intake. Exogenous melatonin (MLT) administration has been shown to improve circadian rhythm misalignment, postural balance and quality of life and to mitigate cholesterol metabolism, inflammatory markers and hyperglycemia as well as to promote sleep and improve its quality. This study aimed to examine to evaluate the safety and the efficiency of exogenous MLT administration combined with a concurrent training program performed throughout Ramadan diurnal intermittent fasting on body composition, biomarkers of metabolic heath and sleep quality, quality of life and postural balance in overweight/ obese sedentary women.

ICD-10 classifications
Endocrine, nutritional and metabolic diseasesPersonal history of endocrine, nutritional and metabolic diseasesOther postprocedural endocrine and metabolic disordersFamily history of other endocrine, nutritional and metabolic diseasesPostprocedural endocrine and metabolic disorders, not elsewhere classified
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202306614083752
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202306614083752 through Pure Global AI's free database. This Phase 3 trial is sponsored by Research Laboratory molecular bases of human pathology LR19ES13 Faculty of medicine of Sfax and is currently Completed. The study focuses on Nutritional, Metabolic, Endocrine.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.